Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Yamamichi N, Miyata Y, Ikeda N, Yamamoto S, Fukuda H, Yoshida S; Japan Clinical Oncology Group Study (JCOG9205). Ohtsu A, et al. Among authors: saito h. J Clin Oncol. 2003 Jan 1;21(1):54-9. doi: 10.1200/JCO.2003.04.130. J Clin Oncol. 2003. PMID: 12506170 Clinical Trial.
Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
Yamao T, Shimada Y, Shirao K, Ohtsu A, Ikeda N, Hyodo I, Saito H, Iwase H, Tsuji Y, Tamura T, Yamamoto S, Yoshida S. Yamao T, et al. Among authors: saito h. Jpn J Clin Oncol. 2004 Jun;34(6):316-22. doi: 10.1093/jjco/hyh063. Jpn J Clin Oncol. 2004. PMID: 15333683 Clinical Trial.
Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
Saito H, Takada Y, Ichinose Y, Eguchi K, Kudoh S, Matsui K, Nakagawa K, Takada M, Negoro S, Tamura K, Ando M, Tada T, Fukuoka M; West Japan Thoracic Oncology Group 9902. Saito H, et al. J Clin Oncol. 2006 Nov 20;24(33):5247-52. doi: 10.1200/JCO.2006.07.1605. J Clin Oncol. 2006. PMID: 17114657 Clinical Trial.
A late phase II study of S-1 for metastatic pancreatic cancer.
Okusaka T, Funakoshi A, Furuse J, Boku N, Yamao K, Ohkawa S, Saito H. Okusaka T, et al. Among authors: saito h. Cancer Chemother Pharmacol. 2008 Apr;61(4):615-21. doi: 10.1007/s00280-007-0514-8. Epub 2007 May 23. Cancer Chemother Pharmacol. 2008. PMID: 17520253 Clinical Trial.
Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
Boku N, Ohtsu A, Yoshida S, Shirao K, Shimada Y, Hyodo I, Saito H, Miyata Y; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (GIOSG/JCOG). Boku N, et al. Among authors: saito h. Jpn J Clin Oncol. 2007 Apr;37(4):275-81. doi: 10.1093/jjco/hym015. Epub 2007 May 23. Jpn J Clin Oncol. 2007. PMID: 17522103
The Japanese guidelines for gastric cancer screening.
Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T. Hamashima C, et al. Among authors: saito h. Jpn J Clin Oncol. 2008 Apr;38(4):259-67. doi: 10.1093/jjco/hyn017. Epub 2008 Mar 14. Jpn J Clin Oncol. 2008. PMID: 18344316 Review.
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, Koizumi W, Saito H, Yamaguchi K, Takiuchi H, Nasu J, Ohtsu A; Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group. Boku N, et al. Among authors: saito h. Lancet Oncol. 2009 Nov;10(11):1063-9. doi: 10.1016/S1470-2045(09)70259-1. Epub 2009 Oct 7. Lancet Oncol. 2009. PMID: 19818685 Clinical Trial.
8,626 results